Spasticity Market: Industry Analysis, Epidemiology, Pipeline Therapies, Treatment and Companies
- Ankit Nigam
- Jul 25, 2021
- 2 min read
Spasticity is defined as “sensorimotor disorder characterized by a velocity-dependent increase in tonic stretch reflexes with exaggerated tendon jerks, resulting from hyperexcitability of the stretch reflex” or from an upper motor neuron lesion (UMN), presenting as an intermittent or sustained involuntary activations of muscles. The region and the extent of impairment depend on the area of the brain or spinal cord that has been damaged. It can occur in the upper and/or lower limbs.
DelveInsight's " Spasticity Market Insights, Epidemiology, and Market Forecast-2030" report delivers an in-depth understanding of the Spasticity, historical and forecasted epidemiology as well as the Spasticity market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Some Key Highlights from the Spasticity Market Report:
· In the US, about 764,000 children and adults currently have Cerebral Palsy and around 500,000 children under age of 18 currently have Cerebral Palsy.
· In UK the prevalence of CP is 186 per 100,000 population, such that a total of 110,000 people are affected.
· Spasticity affects approximately 35% of those with stroke, more than 90% with CP, about 50% of Traumatic brain injury (TBI) patients, 40% of SCI patients, and between 37% and 78% of MS patients.
· According to DelveInsight’s analysis, Children are affected more with Spasticity as compared to adult.
· United States has the highest percentage of Prevalent diagnosed & treated patients
To gain more insights request sample @ https://www.delveinsight.com/report-store/spasticity-market
Spasticity is the most commonly reported symptom for Multiple sclerosis, seen in 90% of patients. Most cases of spasticity can be subdivided into spinal or cerebral spasticity. Spinal spasticity results from the removal or destruction of supraspinal control and leads to increased excitability of motor neurons, whereas cerebral spasticity stems from a loss of descending inhibition.
The American Association of Neurological Surgeons estimated that spasticity affects more than 12 million people worldwide.
To gain more insights request sample @ https://www.delveinsight.com/report-store/spasticity-market
Some of the Spasticity Companies:
Osmotica Pharmaceuticals,
Revance Therapeutics
Bionorica SE
Merz Pharmaceuticals
GW Pharmaceuticals Ltd.
And Many Others
Spasticity Pipeline Therapies:
Arbaclofen ER
DAXI
BX-1
And Many Others
To gain more insights request sample @ https://www.delveinsight.com/report-store/spasticity-market
Table of Contents
1.
Report Introduction
2.
Executive Summary of Spasticity
3.
Spasticity Market Overview at a Glance
4.
Disease Background and Overview: Spasticity
5.
Case Reports of Spasticity
6.
Spasticity Patient Journey
7.
Spasticity Epidemiology and Patient Population
8.
Epidemiology of Spasticity by Countries (2018–2030)
9.
Spasticity Treatments and Medical Practices
10.
Spasticity Marketed Therapies
11.
Spasticity Emerging Therapies
12.
Spasticity Market Size
13.
7MM: Country-wise Market Analysis
14.
Spasticity Market Drivers
15.
Spasticity Market Barriers
16.
SWOT Analysis
17.
KOL Views
18.
Reimbursement and market access
19.
Report Methodology
20.
DelveInsight Capabilities
21.
Disclaimer
22.
About DelveInsight
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end to end comprehensive solutions to improve their performance.
Spasticity market,Spasticity market trends,Spasticity market forecast,Spasticity market share,Spasticity pipeline,Spasticity treatment algorithm,Spasticity drugs,Spasticity market size,Spasticity CAGR,Spasticity epidemiology
Comments